Clinical Trial
doi: 10.1097/01.jcp.0000270082.30500.69.
Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism
- PMID: 17502791
- DOI: 10.1097/01.jcp.0000270082.30500.69
Item in Clipboard
Clinical Trial
Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism
J Clin Psychopharmacol.
2007 Jun.
No abstract available
Similar articles
-
Treating autism pharmacologically: also tacrine might improve symptomatology in some cases.J Child Neurol. 2007 Aug;22(8):1054; author reply 1054-5. doi: 10.1177/0883073807305857. J Child Neurol. 2007. PMID: 17761662 No abstract available.
-
Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.J Child Neurol. 2007 May;22(5):574-9. doi: 10.1177/0883073807302611. J Child Neurol. 2007. PMID: 17690064 Clinical Trial.
-
Is infantile alternating hemiplegia mediated by glutamate toxicity and can it be treated with memantine?Neuropediatrics. 1996 Oct;27(5):277-8. doi: 10.1055/s-2007-973779. Neuropediatrics. 1996. PMID: 8971751 No abstract available.
-
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.J Neural Transm (Vienna). 2014 Aug;121(8):891-905. doi: 10.1007/s00702-014-1216-0. Epub 2014 Apr 22. J Neural Transm (Vienna). 2014. PMID: 24752754 Free PMC article. Review.
-
Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.Dement Geriatr Cogn Disord. 2009;27(2):164-72. doi: 10.1159/000200013. Epub 2009 Feb 5. Dement Geriatr Cogn Disord. 2009. PMID: 19194105 Review.
Cited by
-
Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.Clin Interv Aging. 2009;4:367-77. doi: 10.2147/cia.s6666. Epub 2009 Oct 12. Clin Interv Aging. 2009. PMID: 19851512 Free PMC article. Review.
-
Developing drugs for core social and communication impairment in autism.Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):787-801, viii-ix. doi: 10.1016/j.chc.2008.06.010. Child Adolesc Psychiatr Clin N Am. 2008. PMID: 18775370 Free PMC article. Review.
-
A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.BMC Psychiatry. 2013 Jul 25;13:196. doi: 10.1186/1471-244X-13-196. BMC Psychiatry. 2013. PMID: 23886027 Free PMC article. Clinical Trial.
-
Social Communication is an Emerging Target for Pharmacotherapy in Autism Spectrum Disorder - A Review of the Literature on Potential Agents.J Can Acad Child Adolesc Psychiatry. 2014 Feb;23(1):20-30. J Can Acad Child Adolesc Psychiatry. 2014. PMID: 24516474 Free PMC article.
-
TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.Res Autism Spectr Disord. 2012 Oct 1;6(4):1311-1320. doi: 10.1016/j.rasd.2012.05.007. Res Autism Spectr Disord. 2012. PMID: 23162607 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
